Purchase Order 75N93021P00926
Award Date 7/9/21
Potential Completion Date 7/8/25
Potential Value $47K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Poolesville, MD 20837, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Terumo BCT Inc., a Colorado-based manufacturer of advanced blood and cell technology medical devices, was awarded a $19,039.92 firm fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) on July 9, 2018. The contract represents an option exercise with a performance location in Denver, Colorado, and carries an ultimate completion date of July 8, 2021. This award was not designated as a set-aside contract. Terumo BCT, operating under the doing-business-as...
- This federal contract award is for the procurement of a Spectra Optia Apheresis System with Seal Safe Tubing Sealer, catalog #61000, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency under the U.S. Department of Health and Human Services. The contract was awarded to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services. The contract has a firm fixed price of $61,412.00 and does not have a set-aside...
- This is a purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $5,472.93, is for a full service maintenance agreement for a Spectra Optia apheresis system. The contract has a completion date of July 8, 2015 and uses a firm fixed price pricing type. Terumo BCT has an established track record of providing specialized medical equipment and services to...
- This federal contract award, valued at $44,963.38, was issued by the National Institutes of Health (NIH) Clinical Center to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services. The contract is for the procurement of Optia apheresis machines and related preventative maintenance services, with a period of performance from June 27, 2025 to June 26, 2026, and two optional one-year extension periods. This is a firm-fixed-price purchase...
- This federal contract award to Terumo BCT, Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services, is for the procurement of 2 Spectra Optia Apheresis Systems, catalog number 61000. The contract, valued at $183,580.50, is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract has an ultimate completion date of June 30, 2025 and was awarded on May 29, 2025....
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and blood and cell technology services. The $115,466.32 contract is for the supply of specialized medical equipment, consumables, and maintenance services, with a focus on blood management technologies, apheresis systems, and related medical supplies. The contract is not set aside for small businesses....
- This federal contract award was made by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse to Terumo BCT, Inc., a manufacturer of medical devices and services related to blood and cell technologies. The $149,162 firm fixed-price purchase order contract was awarded on August 11, 2017 with a completion date of October 11, 2017, and did not use a small business set-aside. Terumo BCT has provided a range of blood management products...
- The National Institutes of Health Clinical Center awarded a purchase order valued at $77,280 to Terumo BCT Inc. (doing business as Caridianbct Inc.) on August 6, 2019. This firm fixed-price contract was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with an ultimate completion date of August 23, 2021. The contract was performed at the NIH Clinical Center's Bethesda, Maryland location and carried no small...
- Terumo BCT Inc., doing business as CaridianBCT, has been awarded a $19,356 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH-NIAID) to provide TERUMO SCD-IIB welding wafers and consumable supplies for existing instruments. The products will support research at NIAID, part of the Department of Health and Human Services, with performance taking place in Lakewood, Colorado over a ten-month period concluding in May 2024....
- The Department of Health and Human Services National Institutes of Health Clinical Center has awarded a $173,189.14 firm-fixed-price purchase order to Terumo BCT Inc., a manufacturer of medical devices and provider of blood and cell technology services. The purpose of the contract is to acquire two Optia Automated Blood Cell Separators to replace the current Spectra Optia systems that have exceeded their recommended service life. This contract was not set aside for any particular business size...